Effects of oral testosterone undecanoate treatment for severe hypospadias

Chao Chen1, Chun-Xiu Gong, Wei-Ping Zhang

  • 1Department of Pediatric Urology, Beijing Children's Hospital, Affiliated to Capital Medical University, Beijing, 100045, China.

Insights

Oral testosterone undecanoate treatment improved penile growth and reduced surgical complications in children with microphallic hypospadias. This pretreatment strategy is effective for improving surgical outcomes in pediatric hypospadias cases.

Area of Science:

  • Pediatric Urology
  • Endocrinology
  • Surgical Research

Background:

  • Microphallic hypospadias presents significant surgical challenges.
  • Penile length and surgical outcomes are critical concerns in pediatric hypospadias repair.

Purpose of the Study:

  • To evaluate the efficacy of oral testosterone undecanoate (TU) as a preoperative treatment.
  • To assess the impact of TU on penile growth and surgical complication rates in children with microphallic hypospadias.

Main Methods:

  • A randomized study of 72 children with microphallic hypospadias.
  • Group 1 (n=34) received oral TU preoperatively; Group 2 (n=36) did not.
  • All patients underwent hypospadias repair using established surgical techniques.

Main Results:

  • Significant increases in penile length (1.06 ± 0.53 cm) and diameter (0.30 ± 0.09 cm) were observed in the TU group.
  • The TU group showed significantly lower rates of urethrocutaneous fistulas (5.9% vs 25%) and overall reoperations (14.7% vs 38.9%).
  • No significant differences were found in urethral strictures or diverticula rates between groups.

Conclusions:

  • Preoperative oral testosterone undecanoate effectively promotes temporary penile growth.
  • TU treatment significantly reduces postoperative complications, including fistulas and reoperations, in pediatric hypospadias surgery.
  • This approach offers a promising strategy for improving surgical outcomes in microphallic hypospadias.
Abstract

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.5K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
773
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
3.4K
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
709